What is the projected market valuation of the Pediatric Neurology Devices Market by 2035?

The Pediatric Neurology Devices Market is projected to reach a valuation of 4.096 USD Billion by 2035. Read More

What was the market valuation of the Pediatric Neurology Devices Market in 2024?

In 2024, the market valuation of the Pediatric Neurology Devices Market was 2.074 USD Billion. Read More

What is the expected CAGR for the Pediatric Neurology Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Pediatric Neurology Devices Market during the forecast period 2025 - 2035 is 6.38%. Read More

Which companies are considered key players in the Pediatric Neurology Devices Market?

Key players in the Pediatric Neurology Devices Market include Medtronic, Boston Scientific, Abbott Laboratories, and NeuroPace. Read More

What segment of the Pediatric Neurology Devices Market is projected to grow from 0.6 to 1.2 USD Billion by 2035?

The neurosurgery devices segment is projected to grow from 0.6 to 1.2 USD Billion by 2035. Read More

How much is the electroencephalogram segment expected to be valued by 2035?

The electroencephalogram segment is expected to be valued at 0.9 USD Billion by 2035. Read More

What is the projected valuation for the neuro-oncology segment by 2035?

The neuro-oncology segment is projected to reach a valuation of 0.83 USD Billion by 2035. Read More

Which age group is expected to have the highest market valuation in the Pediatric Neurology Devices Market by 2035?

The children age group is expected to have the highest market valuation, projected at 1.662 USD Billion by 2035. Read More

What is the anticipated growth for the hospitals segment in the Pediatric Neurology Devices Market by 2035?

The hospitals segment is anticipated to grow to a valuation of 1.65 USD Billion by 2035. Read More

What are the projected values for the cerebrospinal fluid (CSF) management devices segment by 2035?

The cerebrospinal fluid (CSF) management devices segment is projected to grow from 0.4 to 0.8 USD Billion by 2035. Read More

Pediatric Neurology Devices Market

ID: MRFR/MED/0122-HCR

115 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Pediatric Neurology Devices Market Size, Application and Growth Analysis By Type (Neurostimulator) By Service & Treatment (Electroencephalogram) Neurological Subspecialties (Stroke) By Age Group (Infants) By End User (Hospitals), By Regions - Industry Forecast to 2035

Pediatric Neurology Devices Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.38%

2024 Market Size$ 2.07 Billion

2025 Market Size$ 2.21 Billion

2035 Market Size$ 4.1 Billion

Key Players

Medtronic

Boston Scientific

Abbott Laboratories

NeuroPace

Natus Medical Incorporated

Stryker Corporation

Trends

Technological Advancements
Increased Awareness and Diagnosis
Focus on Patient-Centric Solutions

Opportunities

Increased Awareness and Diagnosis
Focus on Patient-Centric Solutions
Government Initiatives and Funding

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Type (USD Billion)
  1. 4.1.1 neurosurgery devices
  2. 4.1.2 neurostimulator
  3. 4.1.3 cerebrospinal fluid (CSF) management devices
  4. 4.1.4 others
2. 4.2 Healthcare, BY Service & Treatment (USD Billion)
  1. 4.2.1 electroencephalogram
  2. 4.2.2 intrathecal baclofen therapy
  3. 4.2.3 neurological evaluations
  4. 4.2.4 vagal nerve stimulation
  5. 4.2.5 others
3. 4.3 Healthcare, BY Neurological Subspecialties (USD Billion)
  1. 4.3.1 neuro-oncology
  2. 4.3.2 neuromuscular
  3. 4.3.3 neonatal neurology
  4. 4.3.4 neuro-immunology
  5. 4.3.5 stroke
  6. 4.3.6 others
4. 4.4 Healthcare, BY Age Group (USD Billion)
  1. 4.4.1 neonates
  2. 4.4.2 infants
  3. 4.4.3 children
  4. 4.4.4 adolescents
5. 4.5 Healthcare, BY End User (USD Billion)
  1. 4.5.1 hospitals
  2. 4.5.2 healthcare centers
  3. 4.5.3 neurological research centers
  4. 4.5.4 others
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 NeuroPace (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Natus Medical Incorporated (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Stryker Corporation (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 ElectroCore (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cerebrotech Medical Systems (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TYPE
4. 6.4 US MARKET ANALYSIS BY SERVICE & TREATMENT
5. 6.5 US MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
6. 6.6 US MARKET ANALYSIS BY AGE GROUP
7. 6.7 US MARKET ANALYSIS BY END USER
8. 6.8 CANADA MARKET ANALYSIS BY TYPE
9. 6.9 CANADA MARKET ANALYSIS BY SERVICE & TREATMENT
10. 6.10 CANADA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
11. 6.11 CANADA MARKET ANALYSIS BY AGE GROUP
12. 6.12 CANADA MARKET ANALYSIS BY END USER
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY SERVICE & TREATMENT
16. 6.16 GERMANY MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
17. 6.17 GERMANY MARKET ANALYSIS BY AGE GROUP
18. 6.18 GERMANY MARKET ANALYSIS BY END USER
19. 6.19 UK MARKET ANALYSIS BY TYPE
20. 6.20 UK MARKET ANALYSIS BY SERVICE & TREATMENT
21. 6.21 UK MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
22. 6.22 UK MARKET ANALYSIS BY AGE GROUP
23. 6.23 UK MARKET ANALYSIS BY END USER
24. 6.24 FRANCE MARKET ANALYSIS BY TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY SERVICE & TREATMENT
26. 6.26 FRANCE MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
27. 6.27 FRANCE MARKET ANALYSIS BY AGE GROUP
28. 6.28 FRANCE MARKET ANALYSIS BY END USER
29. 6.29 RUSSIA MARKET ANALYSIS BY TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY SERVICE & TREATMENT
31. 6.31 RUSSIA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
32. 6.32 RUSSIA MARKET ANALYSIS BY AGE GROUP
33. 6.33 RUSSIA MARKET ANALYSIS BY END USER
34. 6.34 ITALY MARKET ANALYSIS BY TYPE
35. 6.35 ITALY MARKET ANALYSIS BY SERVICE & TREATMENT
36. 6.36 ITALY MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
37. 6.37 ITALY MARKET ANALYSIS BY AGE GROUP
38. 6.38 ITALY MARKET ANALYSIS BY END USER
39. 6.39 SPAIN MARKET ANALYSIS BY TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY SERVICE & TREATMENT
41. 6.41 SPAIN MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
42. 6.42 SPAIN MARKET ANALYSIS BY AGE GROUP
43. 6.43 SPAIN MARKET ANALYSIS BY END USER
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY SERVICE & TREATMENT
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY END USER
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY TYPE
51. 6.51 CHINA MARKET ANALYSIS BY SERVICE & TREATMENT
52. 6.52 CHINA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
53. 6.53 CHINA MARKET ANALYSIS BY AGE GROUP
54. 6.54 CHINA MARKET ANALYSIS BY END USER
55. 6.55 INDIA MARKET ANALYSIS BY TYPE
56. 6.56 INDIA MARKET ANALYSIS BY SERVICE & TREATMENT
57. 6.57 INDIA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
58. 6.58 INDIA MARKET ANALYSIS BY AGE GROUP
59. 6.59 INDIA MARKET ANALYSIS BY END USER
60. 6.60 JAPAN MARKET ANALYSIS BY TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY SERVICE & TREATMENT
62. 6.62 JAPAN MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
63. 6.63 JAPAN MARKET ANALYSIS BY AGE GROUP
64. 6.64 JAPAN MARKET ANALYSIS BY END USER
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY SERVICE & TREATMENT
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY END USER
70. 6.70 MALAYSIA MARKET ANALYSIS BY TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY SERVICE & TREATMENT
72. 6.72 MALAYSIA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
73. 6.73 MALAYSIA MARKET ANALYSIS BY AGE GROUP
74. 6.74 MALAYSIA MARKET ANALYSIS BY END USER
75. 6.75 THAILAND MARKET ANALYSIS BY TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY SERVICE & TREATMENT
77. 6.77 THAILAND MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
78. 6.78 THAILAND MARKET ANALYSIS BY AGE GROUP
79. 6.79 THAILAND MARKET ANALYSIS BY END USER
80. 6.80 INDONESIA MARKET ANALYSIS BY TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY SERVICE & TREATMENT
82. 6.82 INDONESIA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
83. 6.83 INDONESIA MARKET ANALYSIS BY AGE GROUP
84. 6.84 INDONESIA MARKET ANALYSIS BY END USER
85. 6.85 REST OF APAC MARKET ANALYSIS BY TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY SERVICE & TREATMENT
87. 6.87 REST OF APAC MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
88. 6.88 REST OF APAC MARKET ANALYSIS BY AGE GROUP
89. 6.89 REST OF APAC MARKET ANALYSIS BY END USER
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY SERVICE & TREATMENT
93. 6.93 BRAZIL MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
94. 6.94 BRAZIL MARKET ANALYSIS BY AGE GROUP
95. 6.95 BRAZIL MARKET ANALYSIS BY END USER
96. 6.96 MEXICO MARKET ANALYSIS BY TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY SERVICE & TREATMENT
98. 6.98 MEXICO MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
99. 6.99 MEXICO MARKET ANALYSIS BY AGE GROUP
100. 6.100 MEXICO MARKET ANALYSIS BY END USER
101. 6.101 ARGENTINA MARKET ANALYSIS BY TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY SERVICE & TREATMENT
103. 6.103 ARGENTINA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
104. 6.104 ARGENTINA MARKET ANALYSIS BY AGE GROUP
105. 6.105 ARGENTINA MARKET ANALYSIS BY END USER
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE & TREATMENT
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY SERVICE & TREATMENT
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY END USER
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY SERVICE & TREATMENT
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY END USER
122. 6.122 REST OF MEA MARKET ANALYSIS BY TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY SERVICE & TREATMENT
124. 6.124 REST OF MEA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
125. 6.125 REST OF MEA MARKET ANALYSIS BY AGE GROUP
126. 6.126 REST OF MEA MARKET ANALYSIS BY END USER
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY TYPE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY SERVICE & TREATMENT, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY SERVICE & TREATMENT, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY NEUROLOGICAL SUBSPECIALTIES, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY NEUROLOGICAL SUBSPECIALTIES, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY END USER, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.2.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.2.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.2.5 BY END USER, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.3.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.3.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.3.5 BY END USER, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.4.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.4.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.4.5 BY END USER, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.5.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.5.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.5.5 BY END USER, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.6.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.6.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.6.5 BY END USER, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.7.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.7.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.7.5 BY END USER, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.8.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.8.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.8.5 BY END USER, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.9.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.9.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.9.5 BY END USER, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.10.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.10.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.10.5 BY END USER, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.11.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.11.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.11.5 BY END USER, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.12.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.12.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.12.5 BY END USER, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.13.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.13.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.13.5 BY END USER, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.14.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.14.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.14.5 BY END USER, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.15.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.15.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.15.5 BY END USER, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.16.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.16.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.16.5 BY END USER, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.17.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.17.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.17.5 BY END USER, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.18.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.18.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.18.5 BY END USER, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.19.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.19.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.19.5 BY END USER, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.20.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.20.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.20.5 BY END USER, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.21.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.21.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.21.5 BY END USER, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.22.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.22.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.22.5 BY END USER, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.23.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.23.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.23.5 BY END USER, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.24.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.24.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.24.5 BY END USER, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.25.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.25.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.25.5 BY END USER, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.26.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.26.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.26.5 BY END USER, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.27.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.27.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.27.5 BY END USER, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.28.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.28.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.28.5 BY END USER, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.29.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.29.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.29.5 BY END USER, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
  3. 7.30.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
  4. 7.30.4 BY AGE GROUP, 2025-2035 (USD Billion)
  5. 7.30.5 BY END USER, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Global Pediatric Neurology Devices Market Segmentation

Global Pediatric Neurology Devices Market By Type (USD Billion, 2025-2035)

neurosurgery devices
neurostimulator
cerebrospinal fluid (CSF) management devices
others

Global Pediatric Neurology Devices Market By Global Pediatric Neurology Devices Market & Treatment (USD Billion, 2025-2035)

electroencephalogram
intrathecal baclofen therapy
neurological evaluations
vagal nerve stimulation
others

Global Pediatric Neurology Devices Market By Neurological Subspecialties (USD Billion, 2025-2035)

neuro-oncology
neuromuscular
neonatal neurology
neuro-immunology
stroke
others

Global Pediatric Neurology Devices Market By Age Group (USD Billion, 2025-2035)

neonates
infants
children
adolescents

Global Pediatric Neurology Devices Market By End User (USD Billion, 2025-2035)

hospitals
healthcare centers
neurological research centers
others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”